Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Aug;94(2):607–615. doi: 10.1172/JCI117376

Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.

Y Hayashi 1, T Sunthornthepvarakul 1, S Refetoff 1
PMCID: PMC296137  PMID: 8040316

Abstract

Thyroid hormone receptor (TR) beta gene mutations identified in patients with resistance to thyroid hormone (RTH) revealed two clusters ("hot" areas) of mutations (RTHmut) in the triiodothyronine (T3)-binding domain. Furthermore, 45% of RTHmuts and 90% of recurring mutations are located in CpG dinucleotides ("hot spots"). To investigate why the region between the two hot areas lacks RTHmuts, we produced 10 artificial mutant TR beta s (ARTmut) in this "cold" region according to the hot spot rule (C-->T or G-->A substitutions in CpGs). The properties of ARTmuts were compared with those of six RTHmuts. Among all RTHmuts, R320H manifesting a mild form of RTH showed the least impairment of T3-binding affinity (Ka). In contrast, Ka was normal in six ARTmuts (group A), reduced to a lesser extent than R320H in three (group B), and one that was truncated (R410X) did not bind T3. All RTHmuts had impaired ability to transactivate T3-responsive elements and exhibited a strong dominant negative effect on cotransfected wild-type TR beta. Group B and A ARTmuts had minimally impaired or normal transactivation and weak or no dominant negative effect, respectively. R410X showed neither transactivation nor dominant negative effect. Natural mutations expected to occur in the cold region of TR beta should fail to manifest as RTH (group A) or should escape detection (group B) since the serum thyroid hormone levels required to compensate for the reduced binding affinity should be inferior to those found in subjects with R320H. R410X would manifest RTH only in the homozygote state. The cold region of the putative T3-binding domain is relatively insensitive to amino acid changes and, thus, may not be involved in a direct interaction with T3.

Full text

PDF
607

Images in this article

608Image
on p.608
611Image
on p.611
611Image
on p.611
612Image
on p.612
612Image
on p.612

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M., Nagaya T., Tone Y., Jameson J. L., Chatterjee V. K. Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome. Clin Endocrinol (Oxf) 1992 Mar;36(3):281–289. doi: 10.1111/j.1365-2265.1992.tb01444.x. [DOI] [PubMed] [Google Scholar]
  2. Au-Fliegner M., Helmer E., Casanova J., Raaka B. M., Samuels H. H. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Biol. 1993 Sep;13(9):5725–5737. doi: 10.1128/mcb.13.9.5725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baniahmad A., Steiner C., Köhne A. C., Renkawitz R. Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell. 1990 May 4;61(3):505–514. doi: 10.1016/0092-8674(90)90532-j. [DOI] [PubMed] [Google Scholar]
  4. Barker D., Schafer M., White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell. 1984 Jan;36(1):131–138. doi: 10.1016/0092-8674(84)90081-3. [DOI] [PubMed] [Google Scholar]
  5. Behr M., Loos U. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Mol Endocrinol. 1992 Jul;6(7):1119–1126. doi: 10.1210/mend.6.7.1324420. [DOI] [PubMed] [Google Scholar]
  6. Boothroyd C. V., Teh B. T., Hayward N. K., Hickman P. E., Ward G. J., Cameron D. P. Single base mutation in the hormone binding domain of the thyroid hormone receptor beta gene in generalised thyroid hormone resistance demonstrated by single stranded conformation polymorphism analysis. Biochem Biophys Res Commun. 1991 Jul 31;178(2):606–612. doi: 10.1016/0006-291x(91)90151-v. [DOI] [PubMed] [Google Scholar]
  7. Burman K. D., Djuh Y. Y., Nicholson D., Rhooms P., Wartofsky L., Fein H. G., Usala S. J., Hao E. H., Bradley W. E., Berard J. Generalized thyroid hormone resistance: identification of an arginine to cystine mutation in codon 315 of the c-erb A beta thyroid hormone receptor. J Endocrinol Invest. 1992 Sep;15(8):573–579. doi: 10.1007/BF03344927. [DOI] [PubMed] [Google Scholar]
  8. Burnside J., Darling D. S., Chin W. W. A nuclear factor that enhances binding of thyroid hormone receptors to thyroid hormone response elements. J Biol Chem. 1990 Feb 15;265(5):2500–2504. [PubMed] [Google Scholar]
  9. Chatterjee V. K., Nagaya T., Madison L. D., Datta S., Rentoumis A., Jameson J. L. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest. 1991 Jun;87(6):1977–1984. doi: 10.1172/JCI115225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cooper D. N., Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet. 1990 Jun;85(1):55–74. doi: 10.1007/BF00276326. [DOI] [PubMed] [Google Scholar]
  11. Cugini C. D., Jr, Leidy J. W., Jr, Chertow B. S., Bérard J., Bradley W. E., Menke J. B., Hao E. H., Usala S. J. An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity. J Clin Endocrinol Metab. 1992 May;74(5):1164–1170. doi: 10.1210/jcem.74.5.1314846. [DOI] [PubMed] [Google Scholar]
  12. Damm K., Thompson C. C., Evans R. M. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature. 1989 Jun 22;339(6226):593–597. doi: 10.1038/339593a0. [DOI] [PubMed] [Google Scholar]
  13. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Forman B. M., Samuels H. H. Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol Endocrinol. 1990 Sep;4(9):1293–1301. doi: 10.1210/mend-4-9-1293. [DOI] [PubMed] [Google Scholar]
  15. Forman B. M., Yang C. R., Au M., Casanova J., Ghysdael J., Samuels H. H. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol. 1989 Oct;3(10):1610–1626. doi: 10.1210/mend-3-10-1610. [DOI] [PubMed] [Google Scholar]
  16. Geffner M. E., Su F., Ross N. S., Hershman J. M., Van Dop C., Menke J. B., Hao E., Stanzak R. K., Eaton T., Samuels H. H. An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype. J Clin Invest. 1993 Feb;91(2):538–546. doi: 10.1172/JCI116233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Glass C. K., Lipkin S. M., Devary O. V., Rosenfeld M. G. Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer. Cell. 1989 Nov 17;59(4):697–708. doi: 10.1016/0092-8674(89)90016-0. [DOI] [PubMed] [Google Scholar]
  18. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  19. Inoue A., Yamakawa J., Yukioka M., Morisawa S. Filter-binding assay procedure for thyroid hormone receptors. Anal Biochem. 1983 Oct 1;134(1):176–183. doi: 10.1016/0003-2697(83)90280-4. [DOI] [PubMed] [Google Scholar]
  20. Mangelsdorf D. J., Ong E. S., Dyck J. A., Evans R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 1990 May 17;345(6272):224–229. doi: 10.1038/345224a0. [DOI] [PubMed] [Google Scholar]
  21. McPhie P., Parkison C., Lee B. K., Cheng S. Y. Structure of the hormone binding domain of human beta 1 thyroid hormone nuclear receptor: is it an alpha/beta barrel? Biochemistry. 1993 Jul 27;32(29):7460–7465. doi: 10.1021/bi00080a017. [DOI] [PubMed] [Google Scholar]
  22. Meier C. A., Dickstein B. M., Ashizawa K., McClaskey J. H., Muchmore P., Ransom S. C., Menke J. B., Hao E. H., Usala S. J., Bercu B. B. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol. 1992 Feb;6(2):248–258. doi: 10.1210/mend.6.2.1569968. [DOI] [PubMed] [Google Scholar]
  23. Meier C. A., Parkison C., Chen A., Ashizawa K., Meier-Heusler S. C., Muchmore P., Cheng S. Y., Weintraub B. D. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. J Clin Invest. 1993 Oct;92(4):1986–1993. doi: 10.1172/JCI116793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mixson A. J., Parrilla R., Ransom S. C., Wiggs E. A., McClaskey J. H., Hauser P., Weintraub B. D. Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. J Clin Endocrinol Metab. 1992 Oct;75(4):1039–1045. doi: 10.1210/jcem.75.4.1400869. [DOI] [PubMed] [Google Scholar]
  25. Mixson A. J., Renault J. C., Ransom S., Bodenner D. L., Weintraub B. D. Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone. Clin Endocrinol (Oxf) 1993 Mar;38(3):227–234. doi: 10.1111/j.1365-2265.1993.tb00999.x. [DOI] [PubMed] [Google Scholar]
  26. Miyamoto T., Suzuki S., DeGroot L. J. High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand-dependent dissociation. Mol Endocrinol. 1993 Feb;7(2):224–231. doi: 10.1210/mend.7.2.8469235. [DOI] [PubMed] [Google Scholar]
  27. Murray M. B., Towle H. C. Identification of nuclear factors that enhance binding of the thyroid hormone receptor to a thyroid hormone response element. Mol Endocrinol. 1989 Sep;3(9):1434–1442. doi: 10.1210/mend-3-9-1434. [DOI] [PubMed] [Google Scholar]
  28. Nagaya T., Jameson J. L. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem. 1993 Jul 25;268(21):15766–15771. [PubMed] [Google Scholar]
  29. Nagaya T., Madison L. D., Jameson J. L. Thyroid hormone receptor mutants that cause resistance to thyroid hormone. Evidence for receptor competition for DNA sequences in target genes. J Biol Chem. 1992 Jun 25;267(18):13014–13019. [PubMed] [Google Scholar]
  30. O'Donnell A. L., Rosen E. D., Darling D. S., Koenig R. J. Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein. Mol Endocrinol. 1991 Jan;5(1):94–99. doi: 10.1210/mend-5-1-94. [DOI] [PubMed] [Google Scholar]
  31. Oppenheimer J. H. Thyroid hormone action at the cellular level. Science. 1979 Mar 9;203(4384):971–979. doi: 10.1126/science.218285. [DOI] [PubMed] [Google Scholar]
  32. Parrilla R., Mixson A. J., McPherson J. A., McClaskey J. H., Weintraub B. D. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest. 1991 Dec;88(6):2123–2130. doi: 10.1172/JCI115542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Refetoff S., Weiss R. E., Usala S. J. The syndromes of resistance to thyroid hormone. Endocr Rev. 1993 Jun;14(3):348–399. doi: 10.1210/edrv-14-3-348. [DOI] [PubMed] [Google Scholar]
  34. Sakurai A., Miyamoto T., Refetoff S., DeGroot L. J. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Mol Endocrinol. 1990 Dec;4(12):1988–1994. doi: 10.1210/mend-4-12-1988. [DOI] [PubMed] [Google Scholar]
  35. Sakurai A., Takeda K., Ain K., Ceccarelli P., Nakai A., Seino S., Bell G. I., Refetoff S., DeGroot L. J. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977–8981. doi: 10.1073/pnas.86.22.8977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sap J., Muñoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., Beug H., Vennström B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature. 1986 Dec 18;324(6098):635–640. doi: 10.1038/324635a0. [DOI] [PubMed] [Google Scholar]
  37. Sasaki S., Nakamura H., Tagami T., Miyoshi Y., Nogimori T., Mitsuma T., Imura H. Pituitary resistance to thyroid hormone associated with a base mutation in the hormone-binding domain of the human 3,5,3'-triiodothyronine receptor-beta. J Clin Endocrinol Metab. 1993 May;76(5):1254–1258. doi: 10.1210/jcem.76.5.8496318. [DOI] [PubMed] [Google Scholar]
  38. Sasaki S., Nakamura H., Tagami T., Miyoshi Y., Tanaka K., Imura H. A point mutation of the T3 receptor beta 1 gene in a kindred of generalized resistance to thyroid hormone. Mol Cell Endocrinol. 1992 Apr;84(3):159–166. doi: 10.1016/0303-7207(92)90026-3. [DOI] [PubMed] [Google Scholar]
  39. Segraves W. A., Hogness D. S. The E75 ecdysone-inducible gene responsible for the 75B early puff in Drosophila encodes two new members of the steroid receptor superfamily. Genes Dev. 1990 Feb;4(2):204–219. doi: 10.1101/gad.4.2.204. [DOI] [PubMed] [Google Scholar]
  40. Shuto Y., Wakabayashi I., Amuro N., Minami S., Okazaki T. A point mutation in the 3,5,3'-triiodothyronine-binding domain of thyroid hormone receptor-beta associated with a family with generalized resistance to thyroid hormone. J Clin Endocrinol Metab. 1992 Jul;75(1):213–217. doi: 10.1210/jcem.75.1.1619012. [DOI] [PubMed] [Google Scholar]
  41. Smith T. J., Murata Y., Horwitz A. L., Philipson L., Refetoff S. Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro. J Clin Invest. 1982 Nov;70(5):1066–1073. doi: 10.1172/JCI110694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Spanjaard R. A., Darling D. S., Chin W. W. Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8587–8591. doi: 10.1073/pnas.88.19.8587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Takeda K., Sakurai A., DeGroot L. J., Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab. 1992 Jan;74(1):49–55. doi: 10.1210/jcem.74.1.1727829. [DOI] [PubMed] [Google Scholar]
  44. Takeda K., Weiss R. E., Refetoff S. Rapid localization of mutations in the thyroid hormone receptor-beta gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J Clin Endocrinol Metab. 1992 Apr;74(4):712–719. doi: 10.1210/jcem.74.4.1548332. [DOI] [PubMed] [Google Scholar]
  45. Usala S. J., Bale A. E., Gesundheit N., Weinberger C., Lash R. W., Wondisford F. E., McBride O. W., Weintraub B. D. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol. 1988 Dec;2(12):1217–1220. doi: 10.1210/mend-2-12-1217. [DOI] [PubMed] [Google Scholar]
  46. Usala S. J., Menke J. B., Watson T. L., Bérard W. E., Bradley C., Bale A. E., Lash R. W., Weintraub B. D. A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance. J Clin Endocrinol Metab. 1991 Jan;72(1):32–38. doi: 10.1210/jcem-72-1-32. [DOI] [PubMed] [Google Scholar]
  47. Usala S. J., Menke J. B., Watson T. L., Wondisford F. E., Weintraub B. D., Bérard J., Bradley W. E., Ono S., Mueller O. T., Bercu B. B. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor. Mol Endocrinol. 1991 Mar;5(3):327–335. doi: 10.1210/mend-5-3-327. [DOI] [PubMed] [Google Scholar]
  48. Usala S. J., Tennyson G. E., Bale A. E., Lash R. W., Gesundheit N., Wondisford F. E., Accili D., Hauser P., Weintraub B. D. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest. 1990 Jan;85(1):93–100. doi: 10.1172/JCI114438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weinberger C., Thompson C. C., Ong E. S., Lebo R., Gruol D. J., Evans R. M. The c-erb-A gene encodes a thyroid hormone receptor. Nature. 1986 Dec 18;324(6098):641–646. doi: 10.1038/324641a0. [DOI] [PubMed] [Google Scholar]
  50. Weiss R. E., Marcocci C., Bruno-Bossio G., Refetoff S. Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab. 1993 Jan;76(1):257–259. doi: 10.1210/jcem.76.1.8421095. [DOI] [PubMed] [Google Scholar]
  51. Weiss R. E., Weinberg M., Refetoff S. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest. 1993 Jun;91(6):2408–2415. doi: 10.1172/JCI116474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yen P. M., Sugawara A., Chin W. W. Triiodothyronine (T3) differentially affects T3-receptor/retinoic acid receptor and T3-receptor/retinoid X receptor heterodimer binding to DNA. J Biol Chem. 1992 Nov 15;267(32):23248–23252. [PubMed] [Google Scholar]
  53. Yen P. M., Sugawara A., Refetoff S., Chin W. W. New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J Clin Invest. 1992 Nov;90(5):1825–1831. doi: 10.1172/JCI116058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zavacki A. M., Harney J. W., Brent G. A., Larsen P. R. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol. 1993 Oct;7(10):1319–1330. doi: 10.1210/mend.7.10.8264663. [DOI] [PubMed] [Google Scholar]
  55. Zhang X. K., Wills K. N., Graupner G., Tzukerman M., Hermann T., Pfahl M. Ligand-binding domain of thyroid hormone receptors modulates DNA binding and determines their bifunctional roles. New Biol. 1991 Feb;3(2):169–181. [PubMed] [Google Scholar]
  56. van der Ploeg L. H., Flavell R. A. DNA methylation in the human gamma delta beta-globin locus in erythroid and nonerythroid tissues. Cell. 1980 Apr;19(4):947–958. doi: 10.1016/0092-8674(80)90086-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES